http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 24 Feb 2026 07:05:11 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Management+Changes/Diality+names+Peter+Donato+as+chief+financial+officer/26046558.html <p>Diality Inc., a medical device company developing hemodialysis systems, appointed Peter Donato as chief financial officer. The company announced the appointment as it continues patient enrollment in its PRESCRIBE Diality Home Hemodialysis Clinical Trial and prepares for a limited market release in 2027.</p> <p>Donato brings nearly 35 years of financial leadership experience, including over 23 years in life sciences companies. He previously served as CFO of heart failure device company Impulse Dynamics and chief financial and administrative officer of companion pet health company Zomedica (NYSE:ZOM). He also held executive positions at Standard Bariatrics, which was sold to Teleflex (NYSE:TFX) for approximately http://www.streetinsider.com/Management+Changes/Diality+names+Peter+Donato+as+chief+financial+officer/26046558.html Tue, 24 Feb 2026 07:05:11 -0500 A.06822034 A.38197016 MYGN O.00001053 O.00058994 O.00171615 O.02295732 O.20026344 STIM TFX ZOM http://www.streetinsider.com/Management+Changes/Diality+names+Peter+Donato+as+chief+financial+officer/26046558.html <p>Diality Inc., a medical device company developing hemodialysis systems, appointed Peter Donato as chief financial officer. The company announced the appointment as it continues patient enrollment in its PRESCRIBE Diality Home Hemodialysis Clinical Trial and prepares for a limited market release in 2027.</p> <p>Donato brings nearly 35 years of financial leadership experience, including over 23 years in life sciences companies. He previously served as CFO of heart failure device company Impulse Dynamics and chief financial and administrative officer of companion pet health company Zomedica (NYSE:ZOM). He also held executive positions at Standard Bariatrics, which was sold to Teleflex (NYSE:TFX) for approximately http://www.streetinsider.com/Management+Changes/Diality+names+Peter+Donato+as+chief+financial+officer/26046558.html Tue, 24 Feb 2026 07:05:11 -0500 A.06822034 A.38197016 MYGN O.00001053 O.00058994 O.00171615 O.02295732 O.20026344 STIM TFX ZOM http://www.streetinsider.com/Management+Changes/Diality+names+Peter+Donato+as+chief+financial+officer/26046558.html <p>Diality Inc., a medical device company developing hemodialysis systems, appointed Peter Donato as chief financial officer. The company announced the appointment as it continues patient enrollment in its PRESCRIBE Diality Home Hemodialysis Clinical Trial and prepares for a limited market release in 2027.</p> <p>Donato brings nearly 35 years of financial leadership experience, including over 23 years in life sciences companies. He previously served as CFO of heart failure device company Impulse Dynamics and chief financial and administrative officer of companion pet health company Zomedica (NYSE:ZOM). He also held executive positions at Standard Bariatrics, which was sold to Teleflex (NYSE:TFX) for approximately http://www.streetinsider.com/Management+Changes/Diality+names+Peter+Donato+as+chief+financial+officer/26046558.html Tue, 24 Feb 2026 07:05:11 -0500 A.06822034 A.38197016 MYGN O.00001053 O.00058994 O.00171615 O.02295732 O.20026344 STIM TFX ZOM http://www.streetinsider.com/Management+Changes/Diality+names+Peter+Donato+as+chief+financial+officer/26046558.html <p>Diality Inc., a medical device company developing hemodialysis systems, appointed Peter Donato as chief financial officer. The company announced the appointment as it continues patient enrollment in its PRESCRIBE Diality Home Hemodialysis Clinical Trial and prepares for a limited market release in 2027.</p> <p>Donato brings nearly 35 years of financial leadership experience, including over 23 years in life sciences companies. He previously served as CFO of heart failure device company Impulse Dynamics and chief financial and administrative officer of companion pet health company Zomedica (NYSE:ZOM). He also held executive positions at Standard Bariatrics, which was sold to Teleflex (NYSE:TFX) for approximately http://www.streetinsider.com/Management+Changes/Diality+names+Peter+Donato+as+chief+financial+officer/26046558.html Tue, 24 Feb 2026 07:05:11 -0500 A.06822034 A.38197016 MYGN O.00001053 O.00058994 O.00171615 O.02295732 O.20026344 STIM TFX ZOM http://www.streetinsider.com/Management+Changes/Diality+names+Peter+Donato+as+chief+financial+officer/26046558.html <p>Diality Inc., a medical device company developing hemodialysis systems, appointed Peter Donato as chief financial officer. The company announced the appointment as it continues patient enrollment in its PRESCRIBE Diality Home Hemodialysis Clinical Trial and prepares for a limited market release in 2027.</p> <p>Donato brings nearly 35 years of financial leadership experience, including over 23 years in life sciences companies. He previously served as CFO of heart failure device company Impulse Dynamics and chief financial and administrative officer of companion pet health company Zomedica (NYSE:ZOM). He also held executive positions at Standard Bariatrics, which was sold to Teleflex (NYSE:TFX) for approximately http://www.streetinsider.com/Management+Changes/Diality+names+Peter+Donato+as+chief+financial+officer/26046558.html Tue, 24 Feb 2026 07:05:11 -0500 A.06822034 A.38197016 MYGN O.00001053 O.00058994 O.00171615 O.02295732 O.20026344 STIM TFX ZOM http://www.streetinsider.com/Management+Changes/Diality+names+Peter+Donato+as+chief+financial+officer/26046558.html <p>Diality Inc., a medical device company developing hemodialysis systems, appointed Peter Donato as chief financial officer. The company announced the appointment as it continues patient enrollment in its PRESCRIBE Diality Home Hemodialysis Clinical Trial and prepares for a limited market release in 2027.</p> <p>Donato brings nearly 35 years of financial leadership experience, including over 23 years in life sciences companies. He previously served as CFO of heart failure device company Impulse Dynamics and chief financial and administrative officer of companion pet health company Zomedica (NYSE:ZOM). He also held executive positions at Standard Bariatrics, which was sold to Teleflex (NYSE:TFX) for approximately http://www.streetinsider.com/Management+Changes/Diality+names+Peter+Donato+as+chief+financial+officer/26046558.html Tue, 24 Feb 2026 07:05:11 -0500 A.06822034 A.38197016 MYGN O.00001053 O.00058994 O.00171615 O.02295732 O.20026344 STIM TFX ZOM http://www.streetinsider.com/Management+Changes/Diality+names+Peter+Donato+as+chief+financial+officer/26046558.html <p>Diality Inc., a medical device company developing hemodialysis systems, appointed Peter Donato as chief financial officer. The company announced the appointment as it continues patient enrollment in its PRESCRIBE Diality Home Hemodialysis Clinical Trial and prepares for a limited market release in 2027.</p> <p>Donato brings nearly 35 years of financial leadership experience, including over 23 years in life sciences companies. He previously served as CFO of heart failure device company Impulse Dynamics and chief financial and administrative officer of companion pet health company Zomedica (NYSE:ZOM). He also held executive positions at Standard Bariatrics, which was sold to Teleflex (NYSE:TFX) for approximately http://www.streetinsider.com/Management+Changes/Diality+names+Peter+Donato+as+chief+financial+officer/26046558.html Tue, 24 Feb 2026 07:05:11 -0500 A.06822034 A.38197016 MYGN O.00001053 O.00058994 O.00171615 O.02295732 O.20026344 STIM TFX ZOM http://www.streetinsider.com/Management+Changes/Diality+names+Peter+Donato+as+chief+financial+officer/26046558.html <p>Diality Inc., a medical device company developing hemodialysis systems, appointed Peter Donato as chief financial officer. The company announced the appointment as it continues patient enrollment in its PRESCRIBE Diality Home Hemodialysis Clinical Trial and prepares for a limited market release in 2027.</p> <p>Donato brings nearly 35 years of financial leadership experience, including over 23 years in life sciences companies. He previously served as CFO of heart failure device company Impulse Dynamics and chief financial and administrative officer of companion pet health company Zomedica (NYSE:ZOM). He also held executive positions at Standard Bariatrics, which was sold to Teleflex (NYSE:TFX) for approximately http://www.streetinsider.com/Management+Changes/Diality+names+Peter+Donato+as+chief+financial+officer/26046558.html Tue, 24 Feb 2026 07:05:11 -0500 A.06822034 A.38197016 MYGN O.00001053 O.00058994 O.00171615 O.02295732 O.20026344 STIM TFX ZOM http://www.streetinsider.com/Management+Changes/Diality+names+Peter+Donato+as+chief+financial+officer/26046558.html <p>Diality Inc., a medical device company developing hemodialysis systems, appointed Peter Donato as chief financial officer. The company announced the appointment as it continues patient enrollment in its PRESCRIBE Diality Home Hemodialysis Clinical Trial and prepares for a limited market release in 2027.</p> <p>Donato brings nearly 35 years of financial leadership experience, including over 23 years in life sciences companies. He previously served as CFO of heart failure device company Impulse Dynamics and chief financial and administrative officer of companion pet health company Zomedica (NYSE:ZOM). He also held executive positions at Standard Bariatrics, which was sold to Teleflex (NYSE:TFX) for approximately http://www.streetinsider.com/Management+Changes/Diality+names+Peter+Donato+as+chief+financial+officer/26046558.html Tue, 24 Feb 2026 07:05:11 -0500 A.06822034 A.38197016 MYGN O.00001053 O.00058994 O.00171615 O.02295732 O.20026344 STIM TFX ZOM http://www.streetinsider.com/Management+Changes/Diality+names+Peter+Donato+as+chief+financial+officer/26046558.html <p>Diality Inc., a medical device company developing hemodialysis systems, appointed Peter Donato as chief financial officer. The company announced the appointment as it continues patient enrollment in its PRESCRIBE Diality Home Hemodialysis Clinical Trial and prepares for a limited market release in 2027.</p> <p>Donato brings nearly 35 years of financial leadership experience, including over 23 years in life sciences companies. He previously served as CFO of heart failure device company Impulse Dynamics and chief financial and administrative officer of companion pet health company Zomedica (NYSE:ZOM). He also held executive positions at Standard Bariatrics, which was sold to Teleflex (NYSE:TFX) for approximately http://www.streetinsider.com/Management+Changes/Diality+names+Peter+Donato+as+chief+financial+officer/26046558.html Tue, 24 Feb 2026 07:05:11 -0500 A.06822034 A.38197016 MYGN O.00001053 O.00058994 O.00171615 O.02295732 O.20026344 STIM TFX ZOM http://www.streetinsider.com/Management+Changes/Diality+names+Peter+Donato+as+chief+financial+officer/26046558.html <p>Diality Inc., a medical device company developing hemodialysis systems, appointed Peter Donato as chief financial officer. The company announced the appointment as it continues patient enrollment in its PRESCRIBE Diality Home Hemodialysis Clinical Trial and prepares for a limited market release in 2027.</p> <p>Donato brings nearly 35 years of financial leadership experience, including over 23 years in life sciences companies. He previously served as CFO of heart failure device company Impulse Dynamics and chief financial and administrative officer of companion pet health company Zomedica (NYSE:ZOM). He also held executive positions at Standard Bariatrics, which was sold to Teleflex (NYSE:TFX) for approximately http://www.streetinsider.com/Management+Changes/Diality+names+Peter+Donato+as+chief+financial+officer/26046558.html Tue, 24 Feb 2026 07:05:11 -0500 A.06822034 A.38197016 MYGN O.00001053 O.00058994 O.00171615 O.02295732 O.20026344 STIM TFX ZOM http://www.streetinsider.com/Press+Releases/Diality+Appoints+Peter+Donato+as+Chief+Financial+Officer/26046553.html <p class="bwalignc"> <b><i>Life sciences veteran brings private and public sector expertise to company </i><i>in midst of growth trajectory</i></b> </p> <p> IRVINE, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.diality.com%2F&amp;esheet=54429214&amp;newsitemid=20260224064413&amp;lan=en-US&amp;anchor=Diality+Inc.&amp;index=1&amp;md5=ae6d66b7dac1c110014cfe19b7e03f8c" shape="rect">Diality Inc.</a>, a medical device company that has developed the <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.diality.com%2Fmoda-flx&amp;esheet=54429214&amp;newsitemid=20260224064413&amp;lan=en-US&amp;anchor=Moda-flx%26%238482%3B+Hemodialysis+System&amp;index=2&amp;md5=313263128836738a4264a4d57acd57de" shape="rect">Moda-<i>flx™ </i>Hemodialysis System</a>, today announced it has named Peter Donato as its chief financial officer. Donato joins the company as it continues to enroll patients in the PRESCRIBE Diality Home Hemodialysis Clinical Trial of its Moda-<i>flx</i> Hemodialysis System while preparing for a limited market release in 2027. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260224064413/en/" http://www.streetinsider.com/Press+Releases/Diality+Appoints+Peter+Donato+as+Chief+Financial+Officer/26046553.html Tue, 24 Feb 2026 07:05:00 -0500 A.06822034 A.38197016 MYGN O.00001053 O.00058994 O.00171615 O.02295732 O.20026344 STIM TFX ZOM http://www.streetinsider.com/Press+Releases/Diality+Appoints+Peter+Donato+as+Chief+Financial+Officer/26046553.html <p class="bwalignc"> <b><i>Life sciences veteran brings private and public sector expertise to company </i><i>in midst of growth trajectory</i></b> </p> <p> IRVINE, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.diality.com%2F&amp;esheet=54429214&amp;newsitemid=20260224064413&amp;lan=en-US&amp;anchor=Diality+Inc.&amp;index=1&amp;md5=ae6d66b7dac1c110014cfe19b7e03f8c" shape="rect">Diality Inc.</a>, a medical device company that has developed the <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.diality.com%2Fmoda-flx&amp;esheet=54429214&amp;newsitemid=20260224064413&amp;lan=en-US&amp;anchor=Moda-flx%26%238482%3B+Hemodialysis+System&amp;index=2&amp;md5=313263128836738a4264a4d57acd57de" shape="rect">Moda-<i>flx™ </i>Hemodialysis System</a>, today announced it has named Peter Donato as its chief financial officer. Donato joins the company as it continues to enroll patients in the PRESCRIBE Diality Home Hemodialysis Clinical Trial of its Moda-<i>flx</i> Hemodialysis System while preparing for a limited market release in 2027. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260224064413/en/" http://www.streetinsider.com/Press+Releases/Diality+Appoints+Peter+Donato+as+Chief+Financial+Officer/26046553.html Tue, 24 Feb 2026 07:05:00 -0500 A.06822034 A.38197016 MYGN O.00001053 O.00058994 O.00171615 O.02295732 O.20026344 STIM TFX ZOM http://www.streetinsider.com/Press+Releases/Diality+Appoints+Peter+Donato+as+Chief+Financial+Officer/26046553.html <p class="bwalignc"> <b><i>Life sciences veteran brings private and public sector expertise to company </i><i>in midst of growth trajectory</i></b> </p> <p> IRVINE, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.diality.com%2F&amp;esheet=54429214&amp;newsitemid=20260224064413&amp;lan=en-US&amp;anchor=Diality+Inc.&amp;index=1&amp;md5=ae6d66b7dac1c110014cfe19b7e03f8c" shape="rect">Diality Inc.</a>, a medical device company that has developed the <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.diality.com%2Fmoda-flx&amp;esheet=54429214&amp;newsitemid=20260224064413&amp;lan=en-US&amp;anchor=Moda-flx%26%238482%3B+Hemodialysis+System&amp;index=2&amp;md5=313263128836738a4264a4d57acd57de" shape="rect">Moda-<i>flx™ </i>Hemodialysis System</a>, today announced it has named Peter Donato as its chief financial officer. Donato joins the company as it continues to enroll patients in the PRESCRIBE Diality Home Hemodialysis Clinical Trial of its Moda-<i>flx</i> Hemodialysis System while preparing for a limited market release in 2027. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260224064413/en/" http://www.streetinsider.com/Press+Releases/Diality+Appoints+Peter+Donato+as+Chief+Financial+Officer/26046553.html Tue, 24 Feb 2026 07:05:00 -0500 A.06822034 A.38197016 MYGN O.00001053 O.00058994 O.00171615 O.02295732 O.20026344 STIM TFX ZOM http://www.streetinsider.com/Press+Releases/Diality+Appoints+Peter+Donato+as+Chief+Financial+Officer/26046553.html <p class="bwalignc"> <b><i>Life sciences veteran brings private and public sector expertise to company </i><i>in midst of growth trajectory</i></b> </p> <p> IRVINE, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.diality.com%2F&amp;esheet=54429214&amp;newsitemid=20260224064413&amp;lan=en-US&amp;anchor=Diality+Inc.&amp;index=1&amp;md5=ae6d66b7dac1c110014cfe19b7e03f8c" shape="rect">Diality Inc.</a>, a medical device company that has developed the <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.diality.com%2Fmoda-flx&amp;esheet=54429214&amp;newsitemid=20260224064413&amp;lan=en-US&amp;anchor=Moda-flx%26%238482%3B+Hemodialysis+System&amp;index=2&amp;md5=313263128836738a4264a4d57acd57de" shape="rect">Moda-<i>flx™ </i>Hemodialysis System</a>, today announced it has named Peter Donato as its chief financial officer. Donato joins the company as it continues to enroll patients in the PRESCRIBE Diality Home Hemodialysis Clinical Trial of its Moda-<i>flx</i> Hemodialysis System while preparing for a limited market release in 2027. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260224064413/en/" http://www.streetinsider.com/Press+Releases/Diality+Appoints+Peter+Donato+as+Chief+Financial+Officer/26046553.html Tue, 24 Feb 2026 07:05:00 -0500 A.06822034 A.38197016 MYGN O.00001053 O.00058994 O.00171615 O.02295732 O.20026344 STIM TFX ZOM http://www.streetinsider.com/Press+Releases/Diality+Appoints+Peter+Donato+as+Chief+Financial+Officer/26046553.html <p class="bwalignc"> <b><i>Life sciences veteran brings private and public sector expertise to company </i><i>in midst of growth trajectory</i></b> </p> <p> IRVINE, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.diality.com%2F&amp;esheet=54429214&amp;newsitemid=20260224064413&amp;lan=en-US&amp;anchor=Diality+Inc.&amp;index=1&amp;md5=ae6d66b7dac1c110014cfe19b7e03f8c" shape="rect">Diality Inc.</a>, a medical device company that has developed the <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.diality.com%2Fmoda-flx&amp;esheet=54429214&amp;newsitemid=20260224064413&amp;lan=en-US&amp;anchor=Moda-flx%26%238482%3B+Hemodialysis+System&amp;index=2&amp;md5=313263128836738a4264a4d57acd57de" shape="rect">Moda-<i>flx™ </i>Hemodialysis System</a>, today announced it has named Peter Donato as its chief financial officer. Donato joins the company as it continues to enroll patients in the PRESCRIBE Diality Home Hemodialysis Clinical Trial of its Moda-<i>flx</i> Hemodialysis System while preparing for a limited market release in 2027. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260224064413/en/" http://www.streetinsider.com/Press+Releases/Diality+Appoints+Peter+Donato+as+Chief+Financial+Officer/26046553.html Tue, 24 Feb 2026 07:05:00 -0500 A.06822034 A.38197016 MYGN O.00001053 O.00058994 O.00171615 O.02295732 O.20026344 STIM TFX ZOM http://www.streetinsider.com/Press+Releases/Diality+Appoints+Peter+Donato+as+Chief+Financial+Officer/26046553.html <p class="bwalignc"> <b><i>Life sciences veteran brings private and public sector expertise to company </i><i>in midst of growth trajectory</i></b> </p> <p> IRVINE, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.diality.com%2F&amp;esheet=54429214&amp;newsitemid=20260224064413&amp;lan=en-US&amp;anchor=Diality+Inc.&amp;index=1&amp;md5=ae6d66b7dac1c110014cfe19b7e03f8c" shape="rect">Diality Inc.</a>, a medical device company that has developed the <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.diality.com%2Fmoda-flx&amp;esheet=54429214&amp;newsitemid=20260224064413&amp;lan=en-US&amp;anchor=Moda-flx%26%238482%3B+Hemodialysis+System&amp;index=2&amp;md5=313263128836738a4264a4d57acd57de" shape="rect">Moda-<i>flx™ </i>Hemodialysis System</a>, today announced it has named Peter Donato as its chief financial officer. Donato joins the company as it continues to enroll patients in the PRESCRIBE Diality Home Hemodialysis Clinical Trial of its Moda-<i>flx</i> Hemodialysis System while preparing for a limited market release in 2027. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260224064413/en/" http://www.streetinsider.com/Press+Releases/Diality+Appoints+Peter+Donato+as+Chief+Financial+Officer/26046553.html Tue, 24 Feb 2026 07:05:00 -0500 A.06822034 A.38197016 MYGN O.00001053 O.00058994 O.00171615 O.02295732 O.20026344 STIM TFX ZOM http://www.streetinsider.com/Press+Releases/Diality+Appoints+Peter+Donato+as+Chief+Financial+Officer/26046553.html <p class="bwalignc"> <b><i>Life sciences veteran brings private and public sector expertise to company </i><i>in midst of growth trajectory</i></b> </p> <p> IRVINE, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.diality.com%2F&amp;esheet=54429214&amp;newsitemid=20260224064413&amp;lan=en-US&amp;anchor=Diality+Inc.&amp;index=1&amp;md5=ae6d66b7dac1c110014cfe19b7e03f8c" shape="rect">Diality Inc.</a>, a medical device company that has developed the <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.diality.com%2Fmoda-flx&amp;esheet=54429214&amp;newsitemid=20260224064413&amp;lan=en-US&amp;anchor=Moda-flx%26%238482%3B+Hemodialysis+System&amp;index=2&amp;md5=313263128836738a4264a4d57acd57de" shape="rect">Moda-<i>flx™ </i>Hemodialysis System</a>, today announced it has named Peter Donato as its chief financial officer. Donato joins the company as it continues to enroll patients in the PRESCRIBE Diality Home Hemodialysis Clinical Trial of its Moda-<i>flx</i> Hemodialysis System while preparing for a limited market release in 2027. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260224064413/en/" http://www.streetinsider.com/Press+Releases/Diality+Appoints+Peter+Donato+as+Chief+Financial+Officer/26046553.html Tue, 24 Feb 2026 07:05:00 -0500 A.06822034 A.38197016 MYGN O.00001053 O.00058994 O.00171615 O.02295732 O.20026344 STIM TFX ZOM http://www.streetinsider.com/Press+Releases/Diality+Appoints+Peter+Donato+as+Chief+Financial+Officer/26046553.html <p class="bwalignc"> <b><i>Life sciences veteran brings private and public sector expertise to company </i><i>in midst of growth trajectory</i></b> </p> <p> IRVINE, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.diality.com%2F&amp;esheet=54429214&amp;newsitemid=20260224064413&amp;lan=en-US&amp;anchor=Diality+Inc.&amp;index=1&amp;md5=ae6d66b7dac1c110014cfe19b7e03f8c" shape="rect">Diality Inc.</a>, a medical device company that has developed the <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.diality.com%2Fmoda-flx&amp;esheet=54429214&amp;newsitemid=20260224064413&amp;lan=en-US&amp;anchor=Moda-flx%26%238482%3B+Hemodialysis+System&amp;index=2&amp;md5=313263128836738a4264a4d57acd57de" shape="rect">Moda-<i>flx™ </i>Hemodialysis System</a>, today announced it has named Peter Donato as its chief financial officer. Donato joins the company as it continues to enroll patients in the PRESCRIBE Diality Home Hemodialysis Clinical Trial of its Moda-<i>flx</i> Hemodialysis System while preparing for a limited market release in 2027. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260224064413/en/" http://www.streetinsider.com/Press+Releases/Diality+Appoints+Peter+Donato+as+Chief+Financial+Officer/26046553.html Tue, 24 Feb 2026 07:05:00 -0500 A.06822034 A.38197016 MYGN O.00001053 O.00058994 O.00171615 O.02295732 O.20026344 STIM TFX ZOM http://www.streetinsider.com/Press+Releases/Diality+Appoints+Peter+Donato+as+Chief+Financial+Officer/26046553.html <p class="bwalignc"> <b><i>Life sciences veteran brings private and public sector expertise to company </i><i>in midst of growth trajectory</i></b> </p> <p> IRVINE, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.diality.com%2F&amp;esheet=54429214&amp;newsitemid=20260224064413&amp;lan=en-US&amp;anchor=Diality+Inc.&amp;index=1&amp;md5=ae6d66b7dac1c110014cfe19b7e03f8c" shape="rect">Diality Inc.</a>, a medical device company that has developed the <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.diality.com%2Fmoda-flx&amp;esheet=54429214&amp;newsitemid=20260224064413&amp;lan=en-US&amp;anchor=Moda-flx%26%238482%3B+Hemodialysis+System&amp;index=2&amp;md5=313263128836738a4264a4d57acd57de" shape="rect">Moda-<i>flx™ </i>Hemodialysis System</a>, today announced it has named Peter Donato as its chief financial officer. Donato joins the company as it continues to enroll patients in the PRESCRIBE Diality Home Hemodialysis Clinical Trial of its Moda-<i>flx</i> Hemodialysis System while preparing for a limited market release in 2027. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260224064413/en/" http://www.streetinsider.com/Press+Releases/Diality+Appoints+Peter+Donato+as+Chief+Financial+Officer/26046553.html Tue, 24 Feb 2026 07:05:00 -0500 A.06822034 A.38197016 MYGN O.00001053 O.00058994 O.00171615 O.02295732 O.20026344 STIM TFX ZOM http://www.streetinsider.com/Press+Releases/Diality+Appoints+Peter+Donato+as+Chief+Financial+Officer/26046553.html <p class="bwalignc"> <b><i>Life sciences veteran brings private and public sector expertise to company </i><i>in midst of growth trajectory</i></b> </p> <p> IRVINE, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.diality.com%2F&amp;esheet=54429214&amp;newsitemid=20260224064413&amp;lan=en-US&amp;anchor=Diality+Inc.&amp;index=1&amp;md5=ae6d66b7dac1c110014cfe19b7e03f8c" shape="rect">Diality Inc.</a>, a medical device company that has developed the <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.diality.com%2Fmoda-flx&amp;esheet=54429214&amp;newsitemid=20260224064413&amp;lan=en-US&amp;anchor=Moda-flx%26%238482%3B+Hemodialysis+System&amp;index=2&amp;md5=313263128836738a4264a4d57acd57de" shape="rect">Moda-<i>flx™ </i>Hemodialysis System</a>, today announced it has named Peter Donato as its chief financial officer. Donato joins the company as it continues to enroll patients in the PRESCRIBE Diality Home Hemodialysis Clinical Trial of its Moda-<i>flx</i> Hemodialysis System while preparing for a limited market release in 2027. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260224064413/en/" http://www.streetinsider.com/Press+Releases/Diality+Appoints+Peter+Donato+as+Chief+Financial+Officer/26046553.html Tue, 24 Feb 2026 07:05:00 -0500 A.06822034 A.38197016 MYGN O.00001053 O.00058994 O.00171615 O.02295732 O.20026344 STIM TFX ZOM http://www.streetinsider.com/Press+Releases/Diality+Appoints+Peter+Donato+as+Chief+Financial+Officer/26046553.html <p class="bwalignc"> <b><i>Life sciences veteran brings private and public sector expertise to company </i><i>in midst of growth trajectory</i></b> </p> <p> IRVINE, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.diality.com%2F&amp;esheet=54429214&amp;newsitemid=20260224064413&amp;lan=en-US&amp;anchor=Diality+Inc.&amp;index=1&amp;md5=ae6d66b7dac1c110014cfe19b7e03f8c" shape="rect">Diality Inc.</a>, a medical device company that has developed the <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.diality.com%2Fmoda-flx&amp;esheet=54429214&amp;newsitemid=20260224064413&amp;lan=en-US&amp;anchor=Moda-flx%26%238482%3B+Hemodialysis+System&amp;index=2&amp;md5=313263128836738a4264a4d57acd57de" shape="rect">Moda-<i>flx™ </i>Hemodialysis System</a>, today announced it has named Peter Donato as its chief financial officer. Donato joins the company as it continues to enroll patients in the PRESCRIBE Diality Home Hemodialysis Clinical Trial of its Moda-<i>flx</i> Hemodialysis System while preparing for a limited market release in 2027. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260224064413/en/" http://www.streetinsider.com/Press+Releases/Diality+Appoints+Peter+Donato+as+Chief+Financial+Officer/26046553.html Tue, 24 Feb 2026 07:05:00 -0500 A.06822034 A.38197016 MYGN O.00001053 O.00058994 O.00171615 O.02295732 O.20026344 STIM TFX ZOM http://www.streetinsider.com/Business+Wire/Diality+Appoints+Peter+Donato+as+Chief+Financial+Officer/26046553.html <p class="bwalignc"> <b><i>Life sciences veteran brings private and public sector expertise to company </i><i>in midst of growth trajectory</i></b> </p> <p> IRVINE, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.diality.com%2F&amp;esheet=54429214&amp;newsitemid=20260224064413&amp;lan=en-US&amp;anchor=Diality+Inc.&amp;index=1&amp;md5=ae6d66b7dac1c110014cfe19b7e03f8c" shape="rect">Diality Inc.</a>, a medical device company that has developed the <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.diality.com%2Fmoda-flx&amp;esheet=54429214&amp;newsitemid=20260224064413&amp;lan=en-US&amp;anchor=Moda-flx%26%238482%3B+Hemodialysis+System&amp;index=2&amp;md5=313263128836738a4264a4d57acd57de" shape="rect">Moda-<i>flx™ </i>Hemodialysis System</a>, today announced it has named Peter Donato as its chief financial officer. Donato joins the company as it continues to enroll patients in the PRESCRIBE Diality Home Hemodialysis Clinical Trial of its Moda-<i>flx</i> Hemodialysis System while preparing for a limited market release in 2027. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260224064413/en/" http://www.streetinsider.com/Business+Wire/Diality+Appoints+Peter+Donato+as+Chief+Financial+Officer/26046553.html Tue, 24 Feb 2026 07:05:00 -0500 A.06822034 A.38197016 MYGN O.00001053 O.00058994 O.00171615 O.02295732 O.20026344 STIM TFX ZOM http://www.streetinsider.com/Business+Wire/Diality+Appoints+Peter+Donato+as+Chief+Financial+Officer/26046553.html <p class="bwalignc"> <b><i>Life sciences veteran brings private and public sector expertise to company </i><i>in midst of growth trajectory</i></b> </p> <p> IRVINE, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.diality.com%2F&amp;esheet=54429214&amp;newsitemid=20260224064413&amp;lan=en-US&amp;anchor=Diality+Inc.&amp;index=1&amp;md5=ae6d66b7dac1c110014cfe19b7e03f8c" shape="rect">Diality Inc.</a>, a medical device company that has developed the <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.diality.com%2Fmoda-flx&amp;esheet=54429214&amp;newsitemid=20260224064413&amp;lan=en-US&amp;anchor=Moda-flx%26%238482%3B+Hemodialysis+System&amp;index=2&amp;md5=313263128836738a4264a4d57acd57de" shape="rect">Moda-<i>flx™ </i>Hemodialysis System</a>, today announced it has named Peter Donato as its chief financial officer. Donato joins the company as it continues to enroll patients in the PRESCRIBE Diality Home Hemodialysis Clinical Trial of its Moda-<i>flx</i> Hemodialysis System while preparing for a limited market release in 2027. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260224064413/en/" http://www.streetinsider.com/Business+Wire/Diality+Appoints+Peter+Donato+as+Chief+Financial+Officer/26046553.html Tue, 24 Feb 2026 07:05:00 -0500 A.06822034 A.38197016 MYGN O.00001053 O.00058994 O.00171615 O.02295732 O.20026344 STIM TFX ZOM http://www.streetinsider.com/Business+Wire/Diality+Appoints+Peter+Donato+as+Chief+Financial+Officer/26046553.html <p class="bwalignc"> <b><i>Life sciences veteran brings private and public sector expertise to company </i><i>in midst of growth trajectory</i></b> </p> <p> IRVINE, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.diality.com%2F&amp;esheet=54429214&amp;newsitemid=20260224064413&amp;lan=en-US&amp;anchor=Diality+Inc.&amp;index=1&amp;md5=ae6d66b7dac1c110014cfe19b7e03f8c" shape="rect">Diality Inc.</a>, a medical device company that has developed the <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.diality.com%2Fmoda-flx&amp;esheet=54429214&amp;newsitemid=20260224064413&amp;lan=en-US&amp;anchor=Moda-flx%26%238482%3B+Hemodialysis+System&amp;index=2&amp;md5=313263128836738a4264a4d57acd57de" shape="rect">Moda-<i>flx™ </i>Hemodialysis System</a>, today announced it has named Peter Donato as its chief financial officer. Donato joins the company as it continues to enroll patients in the PRESCRIBE Diality Home Hemodialysis Clinical Trial of its Moda-<i>flx</i> Hemodialysis System while preparing for a limited market release in 2027. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260224064413/en/" http://www.streetinsider.com/Business+Wire/Diality+Appoints+Peter+Donato+as+Chief+Financial+Officer/26046553.html Tue, 24 Feb 2026 07:05:00 -0500 A.06822034 A.38197016 MYGN O.00001053 O.00058994 O.00171615 O.02295732 O.20026344 STIM TFX ZOM